Janney Montgomery Scott LLC grew its position in The Allstate Co. (NYSE:ALL - Free Report) by 6.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 54,276 shares of the insurance provider's stock after purchasing an additional 3,244 shares during the period. Janney Montgomery Scott LLC's holdings in Allstate were worth $10,464,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ALL. Pathway Financial Advisers LLC raised its holdings in shares of Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider's stock worth $199,642,000 after acquiring an additional 1,047,019 shares during the period. Allspring Global Investments Holdings LLC raised its position in Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider's stock worth $569,114,000 after buying an additional 472,040 shares during the last quarter. TimesSquare Capital Management LLC purchased a new stake in shares of Allstate during the 3rd quarter worth $77,819,000. Los Angeles Capital Management LLC raised its stake in shares of Allstate by 688.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider's stock worth $87,292,000 after buying an additional 401,901 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec grew its holdings in Allstate by 291.9% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 356,065 shares of the insurance provider's stock valued at $67,528,000 after buying an additional 265,213 shares during the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
Allstate Price Performance
Shares of Allstate stock traded down $1.98 during trading on Tuesday, hitting $191.21. 875,610 shares of the stock traded hands, compared to its average volume of 1,943,158. The stock has a market cap of $50.63 billion, a price-to-earnings ratio of 12.38, a PEG ratio of 1.41 and a beta of 0.52. The firm's fifty day moving average is $194.56 and its 200-day moving average is $187.88. The Allstate Co. has a 52 week low of $153.42 and a 52 week high of $209.88. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43.
Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts' consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analysts' expectations of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm's revenue for the quarter was up 14.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.81 EPS. Research analysts expect that The Allstate Co. will post 16.83 EPS for the current fiscal year.
Allstate Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were given a dividend of $0.92 per share. The ex-dividend date was Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.92%. Allstate's dividend payout ratio (DPR) is presently 23.83%.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on ALL shares. Bank of America boosted their target price on Allstate from $216.00 to $233.00 and gave the stock a "buy" rating in a report on Friday, October 18th. Jefferies Financial Group lifted their price target on Allstate from $231.00 to $267.00 and gave the company a "buy" rating in a report on Friday, November 8th. Wells Fargo & Company increased their price objective on shares of Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a report on Tuesday, January 14th. Keefe, Bruyette & Woods boosted their target price on shares of Allstate from $235.00 to $243.00 and gave the stock an "outperform" rating in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. boosted their price objective on Allstate from $205.00 to $207.00 and gave the stock an "overweight" rating in a report on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $218.13.
Check Out Our Latest Research Report on ALL
About Allstate
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.